NEWS
Milner Therapeutics Symposium 2018
This Symposium is an opportunity for scientists from academia and industry to discuss the latest academic and clinical research and how it could be applied in the pharma and biotech industry to develop new treatments. It is our key networking event for Milner...
read more
The Milner Institute’s Namshik Han takes part in a panel discussion at #Impact18
Computational Biology Programme Lead Namshik Han was on the panel at #Impact18 earlier this month, discussing how artificial intelligence is reshaping biotechnology and healthcare sectors. You can listen to Namshik's ideas around AI in healthcare research, including...
read more
Milner facilitates strategic partnership between Nemesis and Shionogi
SHIONOGI INVESTS IN NEMESIS TECHNOLOGY Japanese Pharma Company Joins £1.4M Seed Funding Round for Nemesis Bioscience Nemesis Bioscience today announced the completion of a Seed funding round of £1.4M from a syndicate of new investors including Shionogi & Co Ltd,...
read more
Milner Affiliated company MedAnnex Ltd Receives SMART: SCOTLAND R&D Award
Scottish Enterprise will contribute up to £423,000 towards the industrial development of a novel antibody to treat autoimmune diseases Milner Affiliated company MedAnnex Ltd, an innovative biotechnology company developing new therapies to treat autoimmune diseases,...
read more
Registration is OPEN for The Milner Institute’s 2018 Symposium
Registration for The Milner Therapeutics Symposium is now open! This Symposium is an opportunity for scientists from academia and industry to discuss the latest academic and clinical research and how it could be applied in the pharma and biotech industry to develop...
read more
The Milner Institute’s new building starts to take shape
Our new building is starting to take shape now, ready for the opening in October. The Milner Therapeutics Institute will have research laboratories within the Capella Building, which is on the Cambridge Biomedical Campus. The laboratories will house research groups...
read more
LifeArc and Milner Therapeutics Institute announce a new partnership in artificial intelligence and machine learning for target discovery
London and Cambridge, UK 23 January 2018 – LifeArc®, the UK-based medical research charity and the Milner Therapeutics Institute at the University of Cambridge today announced a new partnership to identify and validate new drug targets in immuno-oncology and...
read more
Genestack joins the Milner Therapeutics Institute
Genestack Press Release, 27 October 2017 “As sequencing technology shrinks to the size of a key ring and emerging technologies make it possible to track changes to the genome at single cell level, then all of a sudden genomics data becomes a streaming and wearable...
read more
Medical Advancement Institute of the Year 2017
We are privileged to receive the Medical Advancement Institute of the Year award from AI Global Media. The award is in recognition of our global alliance, which we have increased from 6 organisations in 2015 to 65 organisations in 2017. Our alliance enables...
read more
Milner Therapeutics Institute announces global therapeutic alliance of 65 organisations
From 6 organisations in 2015 to 65 organisations in 2017, the alliance enables partnerships between pharma, biotech, service providers and academia Cambridge, 3 October 2017 – The Milner Therapeutics Institute at the University of Cambridge announces 65 organisations...
read more